Skip to main content
. 2019 Sep;11(Suppl 14):S1708–S1720. doi: 10.21037/jtd.2019.05.09

Table 3. Indications for referral and listing for COPD.

Referral
   Progressive disease despite optimal medical treatment
   Not a candidate for LVRS
   BODE 5–6
   PaCO2 >50 or PaO2 <60
   FEV1 <25% predicted
Listing
   BODE ≥7
   FEV1<15–20% predicted
   ≥3 exacerbations during the preceding year
   1 severe exacerbation with acute hypercapnic respiratory failure
   Moderate to severe PH

COPD, chronic obstructive pulmonary disease; LVRS, Lung Volume Reduction Surgery; BODE, body mass index, airflow obstruction, dyspnea and exercise capacity index; PaCO2, partial pressure of carbon dioxide; FEV1: forced expiratory volume in 1 second; PH, pulmonary hypertension.